BIOAVAILABILITY OF IBUPROFEN FROM HARD GELATIN CAPSULES CONTAINING DIFFERENT VISCOSITY GRADES OF HYDROXYPROPYLMETHYLCELLULOSE AND SODIUM CARBOXYMETHYLCELLULOSE

被引:19
|
作者
OJANTAKANEN, S
MARVOLA, M
HANNULA, AM
KLINGE, E
NAUKKARINEN, T
机构
[1] UNIV HELSINKI,DEPT PHARM,DIV BIOPHARM & PHARMACOKINET,SF-00014 HELSINKI,FINLAND
[2] UNIV HELSINKI,DEPT PHARM,DIV PHARMACOL & TOXICOL,SF-00014 HELSINKI,FINLAND
[3] UNIV HELSINKI PHARM,HELSINKI,FINLAND
关键词
IBUPROFEN; HARD GELATIN CAPSULES; HYDROXYPROPYLMETHYLCELLULOSE; SODIUM CARBOXYMETHYLCELLULOSE; SUSTAINED-RELEASE;
D O I
10.1016/0928-0987(93)90025-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of viscosity grade (molecular weight group) of the polymer diluent on the bioavailability of ibuprofen from hard gelatin capsules was evaluated in two single-dose (400 mg) cross-over studies in healthy volunteers following an overnight fast. The polymers studied were nonionic hydroxypropylmethylcellulose (HPMC) K100 and K15M, and anionic sodium carboxymethylcellulose (NaCMC) LV, MV and HV. Plain ibuprofen capsules were used for reference. Use of HPMC K15M led to markedly sustained drug absorption from the capsules. The t(max) and C(max) values differed significantly (P < 0.001) from the reference values. The sustaining effect of the lower viscosity grade, K100, was less pronounced. NaCMC-based capsules exhibited sustained-release properties similar to those of the HPMC K100 capsules. In the case of NaCMC, the molecular weight of the polymer had no significant effect on drug absorption. No differences in the extent of bioavailability of ibuprofen between the formulations studied were evident.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 20 条
  • [1] BIOAVAILABILITY OF IBUPROFEN FROM HARD GELATIN CAPSULES CONTAINING SUCRALFATE OR SODIUM ALGINATE AS DILUENT
    OJANTAKANEN, S
    HANNULA, AM
    MARVOLA, M
    KLINGE, E
    MAKIPAA, M
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (05) : 197 - 201
  • [2] Rectal bioavailability of ibuprofen from hard gelatin capsules containing sodium phosphates as adjuvants and soft gelatin capsules or suppositories as references
    Leino, J
    Salmela, O
    Alastalo, H
    Eerikäinen, S
    Klinge, E
    Marvola, M
    STP PHARMA SCIENCES, 1999, 9 (06): : 579 - 585
  • [3] BIOAVAILABILITY OF ERYTHROMYCIN ACISTRATE FROM HARD GELATIN CAPSULES CONTAINING SODIUM-BICARBONATE
    MARVOLA, M
    NYKANEN, S
    NOKELAINEN, M
    PHARMACEUTICAL RESEARCH, 1991, 8 (08) : 1056 - 1058
  • [4] SODIUM ALGINATES AS DILUENTS IN HARD GELATIN CAPSULES CONTAINING IBUPROFEN AS A MODEL-DRUG
    VESKI, P
    MARVOLA, M
    PHARMAZIE, 1993, 48 (10): : 757 - 760
  • [5] EVALUATION OF DIFFERENT VISCOSITY GRADES OF SODIUM CARBOXYMETHYLCELLULOSE AS TABLET DISINTEGRANTS
    KHAN, KA
    RHODES, CT
    PHARMACEUTICA ACTA HELVETIAE, 1975, 50 (04): : 99 - 102
  • [6] Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydroxypropylmethylcellulose
    Dabbagh, MA
    Ford, JL
    Rubinstein, MH
    Hogan, JE
    Rajabi-Siahboomi, AR
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 1999, 4 (03) : 313 - 324
  • [7] ABSORPTION RATE AND BIOAVAILABILITY OF ACETAMINOPHEN FROM HARD GELATIN RECTAL CAPSULES
    HAGENLOCHER, M
    SOLIVA, M
    WITTWER, F
    ZIEGLER, WH
    SPEISER, P
    PHARMAZEUTISCHE INDUSTRIE, 1987, 49 (12): : 1290 - 1294
  • [8] Influence of different excipients on the properties of hard gelatin capsules with metamizole sodium
    Rogowska, Magdalena
    Iwaniak, Karol
    Polski, Andrzej
    Slawinska, Karolina
    Sobotka-Polska, Karolina
    Modrzewska, Joanna
    Poleszak, Ewa
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2016, 29 (03) : 114 - 117
  • [9] DISSOLUTION FROM HARD GELATIN CAPSULES CONTAINING AMINOPHYLLINE MICROCAPSULES
    ELHELW, AEM
    RAMADAN, EM
    ELSAID, Y
    PHARMAZEUTISCHE INDUSTRIE, 1987, 49 (04): : 410 - 412
  • [10] BIOPHARMACEUTICAL EVALUATION OF PSEUDOEPHEDRINE HYDROCHLORIDE CAPSULES CONTAINING DIFFERENT GRADES OF SODIUM ALGINATE
    VESKI, P
    MARVOLA, M
    SMAL, J
    HEISKANEN, I
    JURJENSON, H
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 111 (02) : 171 - 179